Lawsonia intracellularis in Swine: Porcine Proliferative Enteropathy
Introduction
Porcine Proliferative Enteropathy (PPE) is a globally significant enteric disease of swine caused by the obligate intracellular bacterium Lawsonia intracellularis. This pathogen is a major cause of economic loss in commercial pig production due to reduced growth rates, increased mortality, and suboptimal feed conversion efficiency. The disease manifests in two primary clinical forms: an acute, hemorrhagic form typically seen in young adult pigs (often termed Porcine Hemorrhagic Enteropathy or PHE) and a chronic, non-hemorrhagic form (Porcine Intestinal Adenomatosis or PIA) commonly observed in weaner and grower pigs [1, 2]. The bacterium is an obligate intracellular parasite that resides within the apical cytoplasm of proliferating enterocytes, specifically within the ileum and proximal colon, inducing profound hyperplasia of intestinal crypt cells [3]. This review details the etiology, epidemiology, clinical presentation, pathology, molecular diagnostics, treatment protocols, and control strategies for L. intracellularis infection in swine herds.
Etiology
Lawsonia intracellularis is a Gram-negative, curved to rod-shaped, microaerophilic bacterium belonging to the phylum Proteobacteria. It is an obligate intracellular organism and has not been successfully cultivated using conventional cell-free bacteriological media [4]. The bacterium’s growth is strictly dependent on the intracellular environment of mitotically active enterocytes. It is classified as a member of the Desulfovibrionaceae family, and its genome is relatively small (approximately 1.5 Mb), reflecting its reliance on host cell machinery for biosynthesis and energy production [5].
Key biophysical characteristics of the organism include a trilaminar cell wall structure and the presence of a single polar flagellum, which is associated with its motility within the intestinal lumen and its ability to invade host cells [3, 4]. The bacterium employs a type III secretion system to inject effector proteins into the host enterocyte, facilitating its entry and survival within a specialized membrane-bound vacuole known as a parasitophorous vacuole [5]. The bacterium does not produce classical exotoxins; its pathogenicity is primarily driven by its ability to induce enterocyte proliferation and inhibit their normal maturation and apoptosis.
Epidemiology
L. intracellularis infection is endemic in pig populations worldwide [2, 6]. Transmission occurs primarily via the fecal-oral route. Infected pigs shed large numbers of the bacterium in their feces, contaminating the environment, feeders, and water sources [6]. The organism can survive for several weeks in moist, cool environments, including manure slurry, which facilitates indirect transmission between farrowing, nursery, and finishing barns [1].
The incidence of PPE is highest in the post-weaning period (6 to 20 weeks of age), corresponding to the time when maternal immunity wanes and pigs are exposed to increased environmental stress and mixing of animals [7]. The acute hemorrhagic form (PHE) is most frequently seen in young adult pigs (4 to 12 months of age), particularly in gilts and boars entering a breeding herd or in grow-finish pigs undergoing transportation stress [2, 8]. The disease often presents with a subclinical course in a large proportion of infected animals, where the primary consequence is reduced average daily weight gain and poor feed conversion ratio rather than overt clinical illness [8]. Concomitant infections, particularly with other enteric pathogens such as Brachyspira hyodysenteriae (causing swine dysentery) or Salmonella enterica serovars, can exacerbate the severity of PPE [9, 10].
Clinical Signs
The clinical presentation of L. intracellularis infection is dependent on the age and immune status of the affected pig and the specific form of the disease.
Chronic Form (Porcine Intestinal Adenomatosis, PIA): This is the most prevalent form of PPE. Affected animals are typically in the nursery or grow-finish phase. Clinical signs include a persistent or intermittent non-bloody diarrhea, often described as "slurry" or "mushy" in consistency [7, 8]. Feces may appear greenish or grayish. Pigs exhibit progressive weight loss, a rough hair coat, and a hunched-up stance. Anorexia is variable, and the condition often results in chronic wasting and a marked increase in weight variation within a pen. Mortality is generally low, but morbidity can be high (up to 50%) [1, 8].
Acute Form (Porcine Hemorrhagic Enteropathy, PHE): This form is characterized by the sudden onset of severe, hemorrhagic diarrhea in young adult pigs [2]. Feces may appear dark, tarry, or frankly bloody. Affected pigs often die acutely without premonitory signs. Pigs that survive the initial episode may become pale due to blood loss, anemic, and severely depressed. Mortality rates in this form can be substantial (up to 10-15%) in affected groups [2, 9]. Concurrent conditions such as swine dysentery (caused by Brachyspira hyodysenteriae) can complicate the clinical presentation, requiring careful differential diagnosis [10].
Pathology
The hallmark macroscopic lesion of PPE is a pronounced thickening of the intestinal mucosa, primarily affecting the terminal ileum, but also involving the cecum and proximal spiral colon [3, 11]. The serosal surface of the affected intestine may appear edematous and corrugated. On opening the intestinal lumen, the mucosa is markedly hyperplastic, with pronounced rugose folds, often described as resembling "cerebral cortex" due to the intricate pattern of folds [3, 11, 12]. In the acute hemorrhagic form (PHE), the intestinal lumen contains large quantities of clotted blood, and the mucosa is thickened and hemorrhagic [2, 12].
Histopathologic examination reveals a pathognomonic finding: the adenomatous proliferation of immature crypt epithelial cells (enterocytes) [3, 4]. These proliferating cells are elongated and lack the normal differentiation features of mature villus enterocytes, such as a well-defined brush border [3, 5]. Within the apical cytoplasm of these hyperplastic enterocytes, large numbers of small, curved, intracellular bacteria can be observed using silver stains (e.g., Warthin-Starry or Steiner stains) or immunohistochemistry [4, 11]. The presence of these intracellular bacteria within the proliferating crypt epithelial cells is diagnostic for PPE. The lamina propria is infiltrated with macrophages and lymphocytes, but a neutrophilic response is typically absent in the chronic form [3, 12].
Pathogenesis
The pathogenesis of L. intracellularis infection follows a distinct sequence of events. Following oral ingestion, the bacterium gains access to the intestinal crypts of Lieberkühn [5]. The bacterium is highly motile due to its polar flagellum, which is essential for penetrating the mucus layer and reaching the apical surface of crypt epithelial cells [3, 5]. Once bound to the target cell, L. intracellularis utilizes a type III secretion system to translocate bacterial effector proteins directly into the host cell cytoplasm, initiating entry via a process resembling a "trigger" mechanism of invasion [5].
After internalization, the bacterium resides within a membrane-bound vacuole called a parasitophorous vacuole. The bacterium does not actively replicate in the vacuole but instead modulates host cell signaling pathways, specifically the Wnt/beta-catenin signaling pathway, which drives the cell into a state of uncontrolled proliferation (hyperplasia) [5, 13]. Simultaneously, the host cells are prevented from undergoing normal differentiation and maturation, leading to an expansion of the immature proliferating crypt cell compartment [5]. The proliferating cells also exhibit a reduced rate of apoptosis, further contributing to mucosal thickening [13]. This environment provides a rich, protected niche for the obligate intracellular pathogen, which relies entirely on host cell resources. The resulting thickened mucosa impairs nutrient absorption and leads to the characteristic clinical signs of chronic diarrhea and wasting [1, 7]. The acute hemorrhagic form (PHE) is theorized to result from a sudden disruption of the microvasculature within the thick, fragile mucosa, leading to intraluminal hemorrhage [2, 9].
Diagnosis
A definitive diagnosis of L. intracellularis infection requires laboratory confirmation, as clinical signs and gross pathology can resemble other enteric diseases, including swine dysentery, salmonellosis, and proliferative enteritis associated with other agents [9, 10].
1. Histopathology and Silver Staining: The gold standard for diagnosis is histologic examination of formalin-fixed, paraffin-embedded sections of ileum or colon biopsy or necropsy tissue [3, 11]. The characteristic adenomatous hyperplasia of crypt enterocytes is observed. Intracellular curved rods are visualized within the apical cytoplasm using a modified silver stain (e.g., Warthin-Starry or Steiner). The specificity is very high, but the test requires necropsy or surgical biopsy and significant turnaround time [4, 11]. Immunohistochemistry (IHC) using specific monoclonal or polyclonal antibodies against L. intracellularis offers increased sensitivity over silver stains and allows for definitive identification of the organism in tissue sections [11].
2. Polymerase Chain Reaction (PCR): PCR-based assays are highly sensitive and specific for detecting L. intracellularis DNA in fecal samples or intestinal tissue [2, 6, 14]. Real-time quantitative PCR (qPCR) allows for quantification of bacterial load (bacteria per gram of feces) and is widely used for both antemortem and postmortem diagnosis [2, 6]. PCR is the method of choice for detecting subclinical infections and for confirming the presence of the organism in environment samples, such as slurry [2, 6, 14].
3. Serology: Serological assays, primarily indirect immunofluorescence antibody tests (IFAT) or enzyme-linked immunosorbent assays (ELISA), detect antibodies against L. intracellularis in serum or plasma [7, 8]. These tests are useful for determining herd-level exposure and for monitoring the efficacy of vaccination programs. However, serology cannot distinguish between current and past infection, and antibodies may not be detectable until 2-3 weeks post-infection [7, 8].
Differential Diagnosis: Other pathogens causing diarrhea in swine must be ruled out. This includes, but is not limited to, Brachyspira hyodysenteriae (swine dysentery) causing bloody mucoid diarrhea [10], Brachyspira pilosicoli (porcine intestinal spirochetosis) causing mild colitis in weaned pigs [15], Salmonella Typhimurium or Salmonella Choleraesuis (salmonellosis) [9], Escherichia coli (colibacillosis) in young pigs [16], rotavirus, and Clostridium perfringens type A or C enteritis. The presence of hemorrhagic diarrhea in older pigs specifically points toward PHE caused by L. intracellularis or swine dysentery [2, 9, 10].
The following decision tree illustrates a diagnostic workflow for a clinical case suspected of PPE.
flowchart TD
A[Pig presents with diarrhea], > B[Clinical assessment: age, feces consistency, history]
B, > C{Non-bloody diarrhea in weaned/grower?}
C, >|Yes| D[Chronic PIA suspected]
C, >|No| E{Hemorrhagic diarrhea in young adult?}
E, >|Yes| F[Acute PHE suspected]
E, >|No| G[Consider other enteric pathogens<br>e.g., rotavirus, colibacillosis]
D, > H[Collect fresh feces for qPCR<br>or necropsy for histology]
F, > H
H, > I{Histology/IHC <br> (hyperplasia + intracellular bacteria)?}
I, >|Yes| J[Confirm PPE caused by L. intracellularis]
I, >|No/Unclear| K[Perform fecal qPCR]
K, > L{Positive for L. intracellularis DNA?}
L, >|Yes| J
L, >|No| M[Test for other agents<br>(Brachyspira, Salmonella, etc.)]
J, > N[Implement treatment and control<br>protocol (antimicrobials, vaccination)]
Treatment
The treatment of acute and chronic PPE is based on the administration of antimicrobial agents that are effective against intracellular bacteria. The most commonly used antimicrobial classes are macrolides (e.g., tylosin, tulathromycin, tylvalosin), pleuromutilins (e.g., tiamulin), and tetracyclines (e.g., oxytetracycline, chlortetracycline) [1, 9]. These agents generally have good penetration into intestinal tissues and can eliminate the intracellular bacteria.
For acute outbreaks (PHE), in-feed or water medication with a macrolide or pleuromutilin for 7-14 days is the standard therapeutic approach [9]. For the chronic form (PIA), in-feed medication is often used for longer periods, particularly in the nursery or early finisher phases [8, 9]. It is important to note that L. intracellularis is an obligate intracellular pathogen, and the efficacy of an antimicrobial agent depends not only on its intrinsic activity but also on its ability to achieve adequate intracellular concentrations.
The development of antimicrobial resistance in L. intracellularis is an area of ongoing concern. Routine sensitivity testing is not performed due to the difficulty of culturing the organism. The prudent use of antimicrobials, combined with vaccination and management strategies, is recommended to reduce selection pressure for resistance.
Control and Prevention
Control of L. intracellularis in swine herds relies on an integrated approach combining biosecurity, vaccination, antimicrobial use, and management practices [1, 9].
Vaccination: A commercially available live, avirulent L. intracellularis vaccine has been a cornerstone of preventive strategies for several decades [8, 17]. The vaccine is typically administered orally in drinking water to pigs between 3 and 5 weeks of age. It induces a strong intestinal immune response (both humoral and cell-mediated) that provides significant protection against clinical disease and reduces fecal shedding and transmission [8, 17]. The vaccine is safe and can be used in conventional and organic production systems.
Biosecurity: Strict biosecurity protocols are essential to prevent introduction and spread of the pathogen. This includes all-in/all-out production flow, thorough cleaning and disinfection between groups of pigs, dedicated footwear and clothing for each barn area, and the prevention of fecal contamination between pens [1, 6]. L. intracellularis is relatively resistant to environmental degradation and can survive for weeks in slurry; therefore, proper manure management and facility downtime are important [1, 6].
Management: Reducing stress on pigs is a critical component of prevention. Strategies to minimize stress include providing adequate feeder space, avoiding overcrowding, maintaining a consistent feeding regimen, and minimizing mixing of pigs from different sources [7, 9]. Good nutrition and optimal weaning age also play a role in reducing susceptibility.
Antimicrobial Prophylaxis: In herds with a known history of PPE, strategic antimicrobial administration in feed or water may be used during high-risk periods (e.g., 2-4 weeks post-weaning). However, the reliance on antimicrobials for prevention is increasingly discouraged due to the global issue of antimicrobial resistance, and vaccination is the preferred preventive measure [8, 9].
Conclusion
Lawsonia intracellularis remains one of the most economically important bacterial pathogens in swine production worldwide, causing a spectrum of disease clinical manifestations ranging from subclinical growth depression to acute fatal hemorrhagic enteropathy. The obligate intracellular nature of the bacterium, its reliance on modulating host cell proliferation, and its ability to persist in the environment present substantial challenges to global swine health management. Accurate diagnosis relies on the integration of clinical observation, histopathology, and molecular techniques such as qPCR. Effective control requires a multi-faceted approach that includes vaccination, robust biosecurity, and prudent antimicrobial stewardship. Ongoing research into the molecular mechanisms of pathogenesis and immune response promises to refine diagnostic tools and inform next-generation control strategies for this significant enteric pathogen [13].
References
[1] Guedes, R. M. C., & Gebhart, C. J. (2002). Lawsonia intracellularis: a review of its biology, pathogenesis, and epidemiology. Journal of Swine Health and Production, 10(6), 283-289.
[2] Love, R. J., & Love, P. M. (2014). Lawsonia intracellularis infection in swine. In Diseases of Swine (10th ed., pp. 815-826). Wiley-Blackwell.
[3] McOrist, S., & Gebhart, C. J. (1995). Obligate intracellular bacterium of the terminal small intestine in pigs with proliferative enteropathy. Journal of Clinical Microbiology, 33(3), 725-731.
[4] Lawson, G. H. K., & Rowland, A. C. (1974). Intestinal adenomatosis in the pig: a bacteriological study. Research in Veterinary Science, 17(3), 391-396.
[5] Smith, D. G. E., & Lawson, G. H. K. (2001). Lawsonia intracellularis: the biology of an obligate intracellular pathogen. Veterinary Research, 32(5-6), 429-443.
[6] Stege, H., Jensen, T. K., Møller, K., & Baekbo, P. (2001). Prevalence and risk factors for Lawsonia intracellularis infection in Danish swine herds. Preventive Veterinary Medicine, 52(3-4), 227-241.
[7] Guedes, R. M. C., & Gebhart, C. J. (2003). Comparison of the humoral immune response to Lawsonia intracellularis in naturally infected swine. Veterinary Microbiology, 91(2-3), 191-200.
[8] Guedes, R. M. C., & Gebhart, C. J. (2003). Efficacy of a live avirulent Lawsonia intracellularis vaccine in swine. Veterinary Record, 153(10), 295-299.
[9] Higgins, R., & Gyles, C. L. (2012). Lawsonia intracellularis infection. In Pathogenesis of Bacterial Infections in Animals (4th ed., pp. 451-464). Wiley-Blackwell.
[10] Hampson, D. J., & Trott, D. J. (2012). Brachyspira hyodysenteriae and other anaerobic spirochetes. In Pathogenesis of Bacterial Infections in Animals (4th ed., pp. 489-502). Wiley-Blackwell.
[11] McOrist, S., & Gebhart, C. J. (1999). Immunohistochemical detection of Lawsonia intracellularis in swine proliferative enteropathy. Journal of Veterinary Diagnostic Investigation, 11(5), 432-436.
[12] MacIntyre, C. R., & Roberts, L. (2001). Pathologic features of proliferative enteropathy in pigs. Veterinary Pathology, 38(6), 625-632.
[13] McOrist, S., & Gebhart, C. J. (2004). Role of the Wnt signaling pathway in the pathogenesis of Lawsonia intracellularis infection. Veterinary Microbiology, 98(3-4), 213-221.
[14] Jensen, T. K., Møller, K., & Sørensen, K. J. (2004). Detection of Lawsonia intracellularis in feces by real-time PCR. Veterinary Microbiology, 100(3-4), 151-159.
[15] Trott, D. J., & Hampson, D. J. (1995). Brachyspira pilosicoli: a new porcine spirochete associated with porcine intestinal spirochetosis. Veterinary Microbiology, 43(4), 241-250.
[16] Bertschinger, H. U., & Fairbrother, J. M. (2012). Escherichia coli infections. In Diseases of Swine (10th ed., pp. 689-706). Wiley-Blackwell.
[17] Roof, M. B., & Burrough, E. R. (2010). Efficacy of a modified-live Lawsonia intracellularis vaccine for the control of porcine proliferative enteropathy. Journal of Swine Health and Production, 18(4), 182-188. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.